Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Imugene, Glucocorticoid receptor (NR3C1), Xanthine oxidase (XDH), CRC01 and the tag heme.
Shares Log-kill hypothesis (Skipper), Cash for transport and food to stop families abandoning curative treatment, Glucocorticoid receptor (NR3C1), A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies and the tag heme.
Shares Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies, Glucocorticoid receptor (NR3C1), RPL10, Harmonise Europe's hospital exemption for academic cell therapies, with one registry and the tag heme.
Shares A Study of CTD402 in T-ALL/LBL Patients, A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex), ARID5B, BAK1 and the tag heme.
Shares Allotera Therapeutics (formerly Wugen), Imugene, Dorocubicel (UM171-expanded cord blood), Peking University People's Hospital.
Shares Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant, Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression, Gamida Cell, TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies.
Shares FGR, FYN, SRMS, A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.